Nodular Sclerosis Hodgkin Lymphoma, Intrathoracic Lymph Nodes (C81.12)

Name of the Condition

• Common Name: Nodular Sclerosis Hodgkin Lymphoma
• Medical Terms: Nodular Sclerosis Hodgkin's Disease, NSHL

Summary

Nodular sclerosis Hodgkin lymphoma (NSHL) is a subtype of Hodgkin lymphoma defined by Reed-Sternberg cells and a fibrous nodular pattern in affected lymph nodes. This specific code (C81.12) indicates involvement of intrathoracic lymph nodes, which commonly include mediastinal or hilar nodes. NSHL is the most common subtype of Hodgkin lymphoma and typically presents with painless lymph node enlargement. It tends to affect young adults and has a favorable prognosis with standard treatment.

Causes

The exact cause of NSHL is not fully understood, but it is believed to result from a combination of genetic and environmental factors. Viral infections, such as Epstein-Barr virus (EBV), may contribute to its development, though not all cases are associated with EBV. Genetic predisposition and immune system interactions are also thought to play a role.

Risk Factors

• Age: Most commonly diagnosed in young adults (15-35 years) and adolescents.
• Gender: Slightly more prevalent in females.
• Family History: Having a first-degree relative with lymphoma may increase risk.
• Epstein-Barr Virus: Prior infection may elevate susceptibility.

Symptoms

• Painless swelling of lymph nodes, often in the chest or neck.
• Persistent fatigue or weakness.
• Unexplained fever or night sweats.
• Unintentional weight loss.
• Cough or shortness of breath (if mediastinal nodes are involved).

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., CT scans or PET scans), and biopsy of affected lymph nodes. Histopathological examination confirms the presence of Reed-Sternberg cells and the characteristic nodular sclerosis pattern. Staging determines the extent of disease, which guides treatment planning.

Treatment Options

Treatment typically includes chemotherapy, often combined with radiation therapy for localized disease. Common regimens include ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) or more intensive protocols for advanced cases. Stem cell transplantation may be considered for relapsed or refractory disease.

Prognosis and Follow-Up

NSHL has a favorable prognosis, with high cure rates, especially when diagnosed at an early stage. Long-term follow-up is recommended to monitor for recurrence or late effects of treatment, such as secondary malignancies or cardiovascular issues.

Complications

Potential complications include treatment-related toxicities (e.g., lung damage from bleomycin), infertility, and an increased risk of secondary cancers. Recurrence may occur in a subset of patients, requiring additional therapy.

Lifestyle & Prevention

No specific lifestyle changes can prevent NSHL, but maintaining overall health, avoiding known carcinogens, and seeking prompt medical attention for persistent symptoms may support early detection.

When to Seek Professional Help

Consult a healthcare provider if you experience persistent, unexplained lymph node swelling, unexplained weight loss, night sweats, or fatigue. Early evaluation is important for timely diagnosis and treatment.

Tips for Medical Coders

Use C81.12 for nodular sclerosis Hodgkin lymphoma with documented involvement of intrathoracic lymph nodes. Ensure documentation specifies the anatomical location to support code assignment. Verify that histopathological confirmation of nodular sclerosis subtype is present in the medical record.